|
|
Volumn 174, Issue 5, 1998, Pages 289-290
|
|
Therapy results of the British ET-1 study for Ewing's sarcoma;Therapieergebnisse der britischen ET-1-Studie beim Ewing-Sarkom.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYCLOPHOSPHAMIDE;
DACTINOMYCIN;
DOXORUBICIN;
VACA PROTOCOL;
VINCRISTINE;
ADOLESCENT;
BONE TUMOR;
CHILD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DISEASE FREE SURVIVAL;
EWING SARCOMA;
FEMALE;
HUMAN;
MALE;
MULTIMODALITY CANCER THERAPY;
PRESCHOOL CHILD;
RADIATION DOSE;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
ADOLESCENT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BONE NEOPLASMS;
CHILD;
CHILD, PRESCHOOL;
COMBINED MODALITY THERAPY;
CYCLOPHOSPHAMIDE;
DACTINOMYCIN;
DISEASE-FREE SURVIVAL;
DOXORUBICIN;
FEMALE;
HUMANS;
MALE;
RADIOTHERAPY DOSAGE;
RANDOMIZED CONTROLLED TRIALS;
SARCOMA, EWING'S;
VINCRISTINE;
MLCS;
MLOWN;
|
|
EID: 0032062722
PISSN: 01797158
EISSN: None
Source Type: Journal
DOI: 10.1007/bf03038726 Document Type: Review |
|
Times cited : (2)
|
|
References (4)
|
